MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific to lay off 106 following Lotus Edge heart valve retirement

Boston Scientific to lay off 106 following Lotus Edge heart valve retirement

By

Boston ScientificBoston Scientific (NYSE:BSX) is set to lay off 106 employees in Minnesota following the retirement of its Lotus Edge device, according to reports.

Bring Me the News reported that the company is permanently laying off the 106 workers at its Maple Grove, Minn. location, having notified the state of Minnesota via a WARN letter, as is required by law. The layoffs will begin on Jan. 19, 2021.

The letter stated that, as a result of the voluntary recall and retirement of its Lotus Edge transcatheter aortic valve repair (TAVR) system announced yesterday, the operational unit associated with it will be closed and the employees will be laid off.

“Unfortunately, the decision to stop investing in the Lotus Edge platform means we will immediately stop all associated production and new product development activities, resulting in the elimination of certain roles,” a Boston Scientific spokesperson told MassDevice via email. “At this time, we anticipate that approximately 100 Minnesota-based and field roles will be eliminated, and we are actively seeking to reduce any impacts through redeployments within Boston Scientific. Approximately 40 of those roles are located in Minnesota. The field-based roles are located throughout the country, and report into the interventional cardiology division which is based in Minnesota.”

The spokesperson noted that the company is not communicating a company-wide number at this time because it is actively seeking to reduce job loss through redeployments within the company. When a change impacts an employee, Boston Scientific has resources in place to support those in transition, the spokesperson said.

Marlborough, Mass.-based Boston Scientific said in a news release yesterday that the recall of all unused inventory of its Lotus Edge transcatheter aortic valve repair (TAVR) system is due to complexities related to the product delivery system and solely that — as the valve has achieved positive and clinically effective performance post-implant.

Because of the additional time and investment required to develop and reintroduce an enhanced delivery system, Boston Scientific officials decided to retire the Lotus product platform immediately, ceasing all related commercial, clinical, research & development and manufacturing activities.

In case you missed it

RSS From Medical Design & Outsourcing

  • 5 medtech companies win coveted Tekne awards
    Five medtech companies recently won some of the top technology awards in the state of Minnesota, known as one of three major medical device hubs in the U.S. The companies competed for the Minnesota Technology Association annual Tekne Awards, which included categories ranging from artificial intelligence and machine learning to “technology for good.” “The Tekne… […]
  • Spectrum Plastics acquires PeelMaster Medical
    Spectrum Plastics Group announced that it has closed on the acquisition of PeelMaster Medical Packaging. Based in Niles, Ill., PeelMaster is a full-service converter of sterile flexible packaging to the medical device market. Founded in 1989, PeelMaster produces pouches, header bags and die-cut lids for medical applications. PeelMaster has been an authorized converter of DuPont… […]
  • The best places to work for medtech sales reps
    Teleflex (NYSE:TFX), ConMed (NSDQ:CNMD) and orthopedic fixation company Acumed top the list of best places to work in medtech sales in the coming year, according to a MedReps.com survey of medical sales representatives. The 10th annual MedReps survey polled more than 2,000 medical sales professionals in October 2020 to get a better understanding of what employees look for… […]
  • Researchers tout probes for validating rapid COVID-19 tests
    Nanoengineers at the University of California San Diego have developed probes that they say could make validating rapid, point-of-care COVID-19 tests easier. The probes, called “positive controls,” are made from virus-like particles and are stable and easy to manufacture, according to a news release. The researchers at UCSD believe the positive controls can improve the… […]
  • How ResMed is advancing sleep and respiratory care
    The COVID-19 pandemic’s propulsion of widespread telehealth adoption has ResMed (NYSE:RMD) eyeing remote technologies for the next phase of its sleep and respiratory businesses. The president of that business for the San Diego-based company, Jim Hollingshead, told Medical Design & Outsourcing in a recent interview that the future lies with remote care and digital health offerings. “Right… […]
  • Stricter Documentation Requirements Pose New Challenges for Medical Device Manufacturers
    By Maurizio Lauria, Brand Manager, STEUTE Meditech Inc. New European guidelines and standards have greatly increased the testing and documentation required in order to introduce a new medical device, making the process even more complex and time-consuming for medical device manufacturers. Additionally, these standards apply not only to the device itself but the user interface,… […]
  • Tips to help bring your medical device from mind to market
    By Bret Ludwig, Ph.D. Senior Product Development Specialist, 3M Medical Materials & Technologies Great medical devices start with an idea—a spark. And from there, it might move to the back of a napkin or a notepad. But as development continues, the process can get trickier and more complex. In fact, turning an idea into a… […]
  • FDA allows dry heat treatment for single-user mask reuse
    The FDA has announced that it will allow the use of dry heat to lower the bioburden on masks used by healthcare workers treating COVID-19 patients. While not authorizing equipment made by a particular company, guidance released last week said healthcare providers may use dry heat to reprocess NIOSH-approved filtering facepiece respirators, such as N95s,… […]
  • Mass General researchers tout low-cost, portable brain imaging scanner
    Researchers at Massachusetts General Hospital are touting a low-cost, portable “head only” MRI scanner that could be used in multiple settings. As opposed to standard costly, immobile MRI scanners that require special infrastructure, the MGH researchers developed a low-cost, compact, portable and low-power scanner that could be mounted in an ambulance, wheeled into a patient’s… […]
  • HHS confirms involvement in presidential transition process
    U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential… […]
  • Swiss scientists make ‘micromachines’ for self-deploying stents and more
    Researchers in Zurich reported today that they have invented a manufacturing technique to build “micromachines” out of metal and plastic in which these two materials are interlocked as closely as links in a chain. These robots are so tiny that they can maneuver through blood vessels and deliver medications to certain points in the body… […]